Quantity performed	20
Exception?	No exception
Es handelt sich hier ausschließlich um hochspezialisierte Tumor-Knie-Endoprothesen zur Rekonstruktion nach Tumoroperationen (DKG-zertifiziertes Sarkomzentrum). Deutschlandweit werden jedes Jahr nur ca. 100 bis 150 Fälle von Knochensarkomen im Bereich des Kniegelenks behandelt. Die Genehmigungsbescheide der Bezirksregierung Düsseldorf für die Jahre 2021-2024 liegen vor. Die herkömmlichen orthopädischen Knie-TEPs erbringt die UM Essen in hoher Stückzahl am Standort der Orthopädie in Essen-Werden.

Complex interventions on the organ system esophagus for adults

Quantity performed	16
Exception?	No exception

Complex operations on the pancreatic organ system

Quantity performed	45
Exception?	No exception

Liver transplantation (including partial liver donation)

Quantity performed	52
Exception?	No exception

Kidney transplant (including living donation)

Quantity performed	84
Exception?	No exception

Stem cell transplant

Quantity performed	272
Exception?	No exception

Care of premature and mature infants (with an admission weight < 1250g)

Quantity performed	25
Exception?	No exception

Minimum quantities forecast

Knee joint total endoprostheses

Overall result forecast presentation:	yes
Quantity performed reporting year:	20
Quantity forecast year:	28
Examination by state associations?	no
Exemption?	no
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Complex interventions on the organ system esophagus for adults

Overall result forecast presentation:	yes
Quantity performed reporting year:	16
Quantity forecast year:	20
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Complex operations on the pancreatic organ system

Overall result forecast presentation:	yes
Quantity performed reporting year:	45
Quantity forecast year:	40
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Liver transplantation (including partial liver donation)

Overall result forecast presentation:	yes
Quantity performed reporting year:	52
Quantity forecast year:	48
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Kidney transplantation (including living donation)

Overall result forecast presentation:	yes
Quantity performed reporting year:	84
Quantity forecast year:	86
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Stem cell transplant

Overall result forecast presentation:	yes
Quantity performed reporting year:	272
Quantity forecast year:	282
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Care of premature and mature infants (with an admission weight < 1250g)

Overall result forecast presentation:	yes
Quantity performed reporting year:	25
Quantity forecast year:	27
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Surgical treatment of breast cancer (mamma surgery)

Overall result forecast presentation:	yes
Quantity performed reporting year:	332
Quantity forecast year:	359
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01	Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ02	Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases
CQ05	Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ24	Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022)
CQ25	Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: yes

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
522	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
188	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
182	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
No care for children and young people

SOPs "Vorgehen bei V.a. Kindesmisshandlung, -missbrauch und -vernachlässigung" (letzte Aktualisierung: 14.08.2023) und "Diagnostik bei Verdacht auf Gefährdung von Kindeswohl und Kindergesundheit (OPS 1-945.0-1)" (letzte Aktualisierung: 27.04.2022) wurden erstellt. Eine Schulung der Mitarbeiter ist für 2024 geplant.

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Use of standardised forms for drug medical history

ID Pharma

30.12.2022

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

QMH UK Essen

30.12.2022

SOP on good prescription practices

QMH UK Essen

30.12.2022

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Lehraufträge werden vorrangig in den Bereichen Allgemeinmedizin, Naturheilkunde, Rehabilitationsmedizin vergeben, aber auch zu medizinverwandten Themen.

FL02 - Lectureships / teaching posts at universities of applied sciences

Explanation

FL03 - Student training (clinical traineeship / internship year)

Explanation

Im Jahr 2022 haben 226 Studierende ihr Studium der Humanmedizin im 1. Fachsemester an der Medizinischen Fakultät aufgenommen. Im WS 2022/2023 waren insgesamt 2.248 Studierende an der Fakultät eingeschrieben. Im Jahr 2022 haben 287 Studierende das Studium abgeschlossen.

FL04 - Project-related cooperation with colleges and universities

Explanation

FL05 - Participation in multi-centre Phase I/II studies

Explanation

FL06 - Participation in multi-centre phase III/IV studies

Explanation

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

FL08 - Editors of scientific journals/textbooks

Explanation

FL09 - Doctoral supervision

Explanation

Training

Training in other healing professions

HB01 - Nurse and health care worker (m/f)

Comment

Pflegefachfrau/-mann

HB02 - Health and paediatric nurse (m/f)

Comment

Pflegefachfrau/-mann mit Vertiefungspunkt Pädiatrie

HB03 - Physical therapist / physiotherapist (m/f)

Comment

Fachschule für Physiotherapie Fachschule für Masseure und Medizinische Bademeister (in 2022 letzte Abschlussprüfung)

HB05 - Medical technical radiology assistant (MTRA) (m/f)

Comment

HB07 - Surgical technical assistant (m/f)

Comment

HB09 - Speech therapist (m/f)

Comment

HB12 - Medical technical laboratory assistant (MTLA) (m/f)

Comment

HB15 - Anaesthesia technical assistant (m/f)

Comment

HB16 - Dietician (m/f)

Comment

HB17 - Auxiliary nurse (m/f)

Comment

Pflegefachassistentin/Pflegefachassistent

HB19 - Nursing professionals

Comment

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 27
- Additional staff: 29
- Nursing staff regulation

Service contact persons

Patient advocates

Frau Angela Effing-Sagel

Patientenfürsprecherin

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-2515
Mail: ed.nesse-ku@rehcerpsreufnetneitap

Frau Christa van de Sand

Patientenfürsprecherin

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-2515
Mail: ed.nesse-ku@rehcerpsreufnetneitap

Frau Angela Effing-Sagel

Patientenfürsprecherin

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-2515
Mail: ed.nesse-ku@rehcerpsreufnetneitap

Customer feedback management

Frau Silke Nick

Stellvertreterin

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-85399
Mail: ed.nesse-ku@negnudlemkceurnetneitap

Frau Martina Beher

Beschwerdemanagementbeauftragte

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-85399
Mail: ed.nesse-ku@negnudlemkceurnetneitap

Frau Silke Nick

Stellvertreterin

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-85399
Mail: ed.nesse-ku@negnudlemkceurnetneitap

Quality management

Herr Oliver Steidle

Leitung Stabsstelle Qualitätsmanagement und klinisches Risikomanagement

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-8052
Mail: ed.nesse-ku@eldiets.revilo

Hygiene officer

Prof. Dr. med. Jochen A. Werner

Ärztlicher Direktor

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-5001
Mail: ed.nesse-ku@renrew.nehcoj

Responsible for drug therapy

Herr Dr. rer. biol. hum. Jochen Schnurrer

Leiter der Apotheke

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-3290
Mail: ed.nesse-ku@rerrunhcs.nehcoj

Accessibility Officer

Frau Martina Beher

Beschwerdemanagementbeauftragte

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-85399
Mail: ed.nesse-ku@negnudlemkceurnetneitap

Company

General contact details of the hospital

Hufelandstr. 55
45147 Essen

Phone: 0201-723-0
Fax: 0201-723-5913
Mail: ed.nesse-ku@ofni

Nursing service management

Frau Andrea Schmidt-Rumposch

Pflegedirektorin

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-2610
Mail: ed.nesse-ku@hcsopmur-tdimhcs.aerdna

Head of administration

Herr Thorsten Kaatze

Kaufmännischer Direktor und Stv. Vorstandsvorsitzender

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-2601
Mail: ed.nesse-ku@eztaak.netsroht

Responsible for the quality report in the hospital management

Prof. Dr. med. Jochen A. Werner

Ärztlicher Direktor und Vorstandsvorsitzender

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-5001
Mail: ed.nesse-ku@renrew.nehcoj

Medical management

Prof. Dr. med. Thorsten Brenner

Stv. Ärztlicher Direktor

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-1401
Mail: ed.nesse-ku@rennerb.netsroht

Prof. Dr. med. Kurt Werner Schmid

Stv. Ärztlicher Direktor; bis 30.06.2022

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-2890
Mail: ed.nesse-ku@dimhcs.wk

Prof. Dr. med. Jochen A. Werner

Ärztlicher Direktor und Vorstandsvorsitzender

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-5001
Mail: ed.nesse-ku@renrew.nehcoj

Prof. Dr. med. Thorsten Brenner

Stv. Ärztlicher Direktor

Hufelandstr. 55
45147 Essen

Phone: 0201 -723-1401
Mail: ed.nesse-ku@rennerb.netsroht

Regional care obligation for psychiatry?

IK number

IK: 260510381

Location number

Location number: 771967000

Old location number: 771967000

Hospital portrait for download